Viewing Study NCT00793650

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search All Studies All Organizations Report Bug

Ignite Creation Date: 2025-12-24 @ 5:06 PM

Ignite Modification Date: 2025-12-24 @ 5:06 PM

Study NCT ID: NCT00793650

Status: TERMINATED

Last Update Posted: 2012-08-30

First Post: 2008-11-17

Is Possible Gene Therapy: False

Has Adverse Events: True

Brief Title: Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study

Sponsor: Emory University

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module